| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10833978 | Molecular Genetics and Metabolism | 2011 | 4 Pages |
Abstract
For the majority of patients CFD is not a clear-cut neurometabolic syndrome but the common result of different genetic, metabolic or unknown processes. Nevertheless, CFD may represent a treatable disease-modifying factor which should therefore be addressed in prospective studies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Sarah Mangold, Nenad Blau, Thomas Opladen, Robert Steinfeld, Britta WeÃling, Klaus Zerres, Martin Häusler,